12 participants
Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-02-21
- Start Date:
- 2011-03-03
- Completion:
- 2020-02-05
Conditions
- Advanced Solid Tumors
- Carcinoid
- Colorectal Cancer
- Locally Advanced
- Lymphoma
- Metastatic Cancer
- Non-Small Cell Lung Cancer
- Sarcoma
- Solid Tumors
Interventions
- DRUG
- BIOLOGICAL